CTIS.eu › Cities › Norway › Tromsoe
Tromsoe
Norway
122 total trials
63 recruiting
2022-502176-23-00
4
Migraine
2023-509392-17-00
5
Relapsed Acute Lymphoblastic Leukemia (ALL)
2024-516723-14-00
6
Rheumatoid Arthritis
2024-519891-17-00
4
Ulcerative colitis
2025-521037-86-00
5
Immune system diseases
2025-521330-29-00
4
Major Depression Disorder (MDD)
2025-521470-34-00
5
episodic cluster headache
2025-521529-34-00
5
chronic cluster headache
2025-523425-17-00
4
Proteinuric kidney diseases
2025-522191-86-00
5
2026-04-02
Focal segmental glomerulosclerosis
2025-522767-15-00
5
2026-01-27
Acute Myeloid Leukemia
2024-517667-23-00
4
2025-12-17
Granulomatous Lymphocytic Interstitial Lung Disease (GLILD)
2024-514879-17-00
5
2025-11-05
Gastric cancer
2024-512753-24-00
5
2025-08-05
Acute Myeloid Leukemia (AML)
2024-512733-32-00
5
2025-03-31
Acute Myeloid Leukemia (AML)
2024-518399-29-00
5
2024-12-27
Testicular cancer
2023-505678-14-00
4
2024-08-19
Ulcerative Colitis
2023-507129-40-00
4
2024-08-06
interstitial lung disease secondary to systemic sclerosis (SSc-ILD)
2023-504307-88-00
5
2024-02-20
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
2023-505000-27-01
4
2023-12-29
newly diagnosed pediatric FLT3-ITD positive and NPM1 wild-type AML
2022-502503-30-00
5
2022-12-15
Acute lymphoblastic leukemia
2022-500966-82-00
5
2020-03-11
Resectable locally advanced squamous cell carcinoma (SCC) of the esoph
2025-523552-31-00
5
2026-05-07
Systemic Lupus Erythematosus
2025-522674-36-00
5
2026-03-24
Metabolic Dysfunction-Associated Steatotic Liver Disease
Showing 1–24 of 122 trials